tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro Feb 2026

Tjoapack

Shaping the Future of the Pharmaceutical Supply Chain

Tjoapack is a global leader in contract pharmaceutical packaging and supply chain solutions, committed to ensuring that life-enhancing healthcare products reach patients safely, reliably, and efficiently around the world. For more than 35 years, Tjoapack has partnered with pharmaceutical and biotech companies to deliver tailored primary and secondary packaging services that support both commercial launches and clinical supply needs.

Founded in 1989, the company has grown from a regional specialist into an internationally trusted Contract Packaging Organization (CPO) with facilities in Europe and the United States, serving clients across more than 40 markets on seven continents.

Tjoapack operates from two strategic hubs: its headquarters in Etten-Leur, the Netherlands, positioned near major European distribution arteries such as the ports of Rotterdam and Antwerp, and its U.S. production site in Clinton, Tennessee, located close to Knoxville’s pharmaceutical distribution network. This global footprint enables Tjoapack to efficiently support both regional and international supply chains while ensuring compliance with regulatory and quality standards worldwide, including EU-GMP and U.S. FDA certifications.


Mission, Vision & Commitment

At its core, Tjoapack exists to connect healthcare producers with the patients who depend on their medicines. The company’s mission is to make healthcare products usable, available, and affordable across diverse global markets. Its vision is to elevate contract packaging and supply chain services to the gold standard in the industry, leveraging deep technical expertise and scalable operational excellence.

Driven by innovation and a focus on quality, Tjoapack continuously invests in advanced technologies, highly skilled teams, and regulatory compliance frameworks that protect product integrity throughout the supply chain. With nearly four decades of experience, Tjoapack is uniquely positioned to address complex pharmaceutical packaging challenges and adapt to the evolving needs of customers worldwide.

Comprehensive Packaging Services

Tjoapack provides a clearly defined portfolio of pharmaceutical packaging services, with a strong focus on regulatory compliance, product integrity, and supply chain reliability. The company’s capabilities are structured across primary packaging of oral solid dose forms and secondary packaging of both oral solids and injectable products, complemented by kitting and serialization services.

1. Primary Packaging – Oral Solid Dose Forms Only

Tjoapack provides primary packaging services exclusively for oral solid dose forms (tablets and capsules).

Primary packaging formats include:

  • Blisters
  • Bottles
  • Unit dose formats

These services are designed to ensure product protection, patient safety, and full compliance with EU-GMP and FDA standards.

Tjoapack does not perform primary packaging of injectable products.

2. Secondary Packaging – Oral Solid Dose Forms

In addition to primary packaging, Tjoapack provides secondary packaging services for oral solid products, including:

  • Labeling
  • Leaflet insertion
  • Cartoning
  • Serialization and aggregation

These services support both clinical and commercial volumes and can be tailored to market-specific regulatory requirements.

3. Secondary Packaging – Injectable Products

For injectable medicines, Tjoapack provides secondary packaging services only.

Capabilities include:

Vials

  • Labeling
  • Cartoning
  • Single and multipack configurations

Pre-Filled Syringes (PFS)

  • Assembly
  • Secondary packaging

All injectable packaging activities are performed with strict control over traceability, documentation, and compliance requirements.

Tjoapack does not perform primary filling or primary packaging of injectable products.

4. Kitting and Assembly Solutions

Tjoapack provides custom kitting and assembly services, combining multiple components into complete, ready-to-distribute packs.

Kits may include:

  • Vials
  • Pre-filled syringes
  • Leaflets
  • Instructions for use (IFUs)
  • Ancillary materials

Kitting solutions are particularly suited for:

  • Clinical trial supply
  • Combination products
  • Specialty and complex therapies

5. Serialization and Regulatory Compliance

To support global market access, Tjoapack offers serialization and aggregation capabilities for both EU and U.S. markets, ensuring compliance with:

  • EU Falsified Medicines Directive (FMD)
  • U.S. Drug Supply Chain Security Act (DSCSA)

These capabilities enhance supply chain transparency, traceability, and product security.

Supply Chain Management & Value-Added Services

Tjoapack’s expertise extends well beyond packaging lines into strategic supply chain services that help clients maintain secure, compliant, and resilient distribution networks:

  • Cold-chain and controlled storage – Facilities capable of ambient, refrigerated (2–8°C), and controlled-temperature freezer storage for sensitive biologics and temperature-controlled drugs.
  • Stock & inventory management – Real-time coordination of goods and materials, tailored to demand signals and client priorities.
  • Logistics coordination – End-to-end transportation planning that aligns with regulatory requirements and project timelines.
  • Clinical trial packaging support – Expertise in handling specialized formats, stability batches, labeling variants, and global shipment requirements for clinical supplies.

Innovation & Infrastructure Growth

Tjoapack continues to expand and modernize its footprint to meet evolving industry demands. Recent initiatives include significant enhancements to its cold chain capabilities and packaging automation infrastructure in both Europe and the U.S., boosting throughput for bottles, vial, auto-injector, and pre-filled syringe packaging lines. These investments help Tjoapack scale with client needs, particularly in the rapidly growing biologics and sterile injectable segments of the industry.

Product Portfolio & Expertise

Tjoapack supports packaging across a wide range of pharmaceutical products, including:

  • Small molecules (oral solid dose, tablets, capsules)
  • Biotech and biologic therapies
  • Injectable formats (vials, pre-filled devices, auto-injectors)
  • Controlled and scheduled substances
  • Orphan, specialty, and light-sensitive drugs
  • Clinical trial materials and regulated product portfolios

Delivering Medicines to Patients Worldwide

At the heart of Tjoapack’s work is a clear purpose: to ensure medicines are available to patients everywhere. By combining focused packaging expertise with regulatory knowledge and supply chain support, Tjoapack enables pharmaceutical companies to bring their products to market safely, efficiently, and with confidence.

SAE Media – AI in DD
YPSOMED website ad
Scott Pharma – 25.03.2025
HCMed
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025